AZP-3601 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
235副甲状腺機能低下症1

235. 副甲状腺機能低下症


臨床試験数 : 88 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05239221
(ClinicalTrials.gov)
September 7, 20207/1/2022AZP-3601 SAD and MAD Study in Healthy Subjects and Subjects With HypoparathyroidismA Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZP-3601, a Synthetic Parathyroid Hormone Analog, in Healthy Subjects and in Subjects With HypoparathyroidismChronic HypoparathyroidismDrug: AZP-3601;Drug: PlaceboAmolyt PharmaNULLCompleted18 Years75 YearsAll132Phase 1Hungary;Netherlands